Infliximab, a tumor necrosis factor-α inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases. © 2007 Elsevier Inc. All rights reserved.
Cryptococcal meningitis in a patient treated with infliximab / Muñoz, Patricia; Giannella, Maddalena; Valerio, Maricela; Soria, Teresa; Díaz, Fernando; Longo, Javier Lopez; Bouza, Emilio. - In: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. - ISSN 0732-8893. - ELETTRONICO. - 57:4(2007), pp. 443-446. [10.1016/j.diagmicrobio.2006.10.014]
Cryptococcal meningitis in a patient treated with infliximab
GIANNELLA, MADDALENA;
2007
Abstract
Infliximab, a tumor necrosis factor-α inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases. © 2007 Elsevier Inc. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
